Skip to main content

fda_recall · drug_recall · critical

Gilead Sciences, Inc. — Class I recall: Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manu…

Event date
2024-10-09 00:00:00Z
Observed
2026-07-16 23:20:07Z
Source ID
D-0005-2025
Payload hash
7de6df0d28459ec51d8bc229…

Summary

Presence of Particulate Matter: Presence of glass particle. Status: Terminated.

Entities

View source record ↗

Frequently asked questions

Has Gilead Sciences, Inc. had other FDA enforcement actions?
Yes. Argus HQ has recorded 4 total FDA actions tied to Gilead Sciences, Inc.: 0 warning letters, 1 recall, 2 approval records, and 1 Form 483 inspection citation.
What kind of FDA record is this?
This is an Argus HQ record of a FDA Recall, tagged critical severity by Argus HQ. FDA published the underlying record on 2024-10-09; Argus observed and indexed it on 2026-07-16.
Where can I verify this record directly with FDA?
The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA
Argus HQ Research (2024). Gilead Sciences, Inc. — Class I recall: Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manu…. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-recall-gilead-sciences-inc-d-0005-2025
MLA
"Gilead Sciences, Inc. — Class I recall: Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manu…." Argus HQ Research, Digital Empire Holdings LLC, 2024, argushq.ai/events/fda-recall-gilead-sciences-inc-d-0005-2025.
Chicago
Argus HQ Research. "Gilead Sciences, Inc. — Class I recall: Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manu…." Digital Empire Holdings LLC. Accessed September 8, 2026. https://argushq.ai/events/fda-recall-gilead-sciences-inc-d-0005-2025.
BibTeX
@misc{argushq_argushq_ai_events_fda_recall_gilead_sciences_inc_d_0005_2025_2024,
  title = {Gilead Sciences, Inc. — Class I recall: Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manu…},
  author = {{Argus HQ Research}},
  year = {2024},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-recall-gilead-sciences-inc-d-0005-2025},
  note = {Accessed: September 8, 2026}
}

Informational only. Not legal, financial, or medical advice.

Gilead Sciences, Inc. — Class I recall: Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manu… · Argus HQ